这5,300多名受试者按照2:2:1的比例随机分配接受Lenacapavir、Descovy和Truvada用于HIV暴露前预防(PrEP)。Lenacapavir是一款衣壳抑制剂,每半年一针,通过 ...
What Truvada is, is a single pill that’s a combination of two antiretroviral drugs that have a long history of being used as part of a broader combination of therapy for the actual treatment of ...
HIV prevention shot achieved a 96% success rate in clinical trials, but accessibility and regulatory hurdles remain a ...
The patent for branded TDF/emtricitabine (Truvada) has expired, allowing multiple manufacturers to offer inexpensive generic versions that contain the same ingredients. Branded TAF/emtricitabine ...
Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court.
New rules mandate that most insurers must now cover the cost. Apretude, Descovy, Truvada, and a generic version of Truvada—often referred to as PrEP—are approved for men at high risk of ...
1 年
Belfast News Letter on MSNNorthern Ireland's foremost gay campaign group the Rainbow Project got £25,000 from pharma ...Northern Ireland's foremost gay campaign group has accepted a five-figure donation from a pharma corporation which has come ...
Terms of the deal were not disclosed in the case, which involved the government’s patents on Gilead’s HIV drugs Truvada and Descovy for pre-exposure prophylaxis (PrEP). The government was ...
(Reuters) - Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware ...
Foster City, California-based Gilead collaborated with the CDC in the mid-2000s to test if Gilead's Truvada could prevent transmission of HIV, the virus that causes AIDS, in addition to treating it.
Gilead Sciences’ Descovy, its successor to HIV pre-exposure prophylaxis (PrEP) therapy Truvada, is heading into an FDA advisory committee meeting on Wednesday with a mostly-positive verdict from ...
Cabotegravir – given the trade name Apretude – can be dosed just six times a year and showed superior results to daily, oral therapy with Gilead's widely used Truvada (emtricitabine and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果